To evaluate the prescription, discontinuation and switching profiles of antihypertensive agents, we studied computerized records for patients prescribed antihypertensive drugs in government primary care clinics of Hong Kong between January 2004 and June 2007, which include 1 069 836 antihypertensive drug visits (representing 67 028 patients). The most commonly prescribed drugs were calcium channel blockers (CCBs, 49%), b-blockers (BBs, 46%) and angiotensin-converting enzyme inhibitors (ACEIs, 19%). Although thiazide diuretic prescribing was low (13%) and on the decline (from 14% in 2004 to 12% in 2007), prescription of ACEIs was rising (from 16% in 2004 to 23% in 2007); drug discontinuation was highest for BBs (21%) and lowest for CCBs (12%) and the high rates of discontinuation in BBs remained apparent after controlling for confounders. CCBs may be particularly favourable antihypertensive drugs in Chinese and the low use of thiazide diuretics warrants further clinical and cost effectiveness studies among Chinese.
The prescribing patterns of antihypertensive agents for Chinese hypertensive patients are not well documented, thus the implications for health policies remained unknown. As persistence with antihypertensive drugs can reduce morbidity and mortality, 1 understanding of discontinuation and switching profiles are important in antihypertensive prescription choices. In this study we report the trends of primary care physician prescriptions of the major antihypertensive classes in the public health care sector in Hong Kong, China. We also compared the discontinuation and switching profiles among various antihypertensive drug classes.
The computerized database of the Hospital Authority of Hong Kong (HA) has completeness in terms of patients' demographic information and prescription details. 2 We included adult patients X18-year old visiting HA primary care clinics at least once between January 2004 and June 2007. The inclusion criteria included general out-patient clinics (GOPCs), family medicine specialist clinics (FMSCs) or staff clinics in the New Territory East cluster of Hong Kong, providing primary health care services to approximately 1.3 million residents. 3 This cluster consists of three regions, namely Shatin, Tai-Po and North district, from the most affluent to the least respectively.
We included all antihypertensive drug visits and excluded patients with known concomitant cardiovascular risk factors or conditions affecting antihypertensive prescriptions, as previously described. 2 To maintain confidentiality, our database contained a unique patient identifier numbers but which could not identify patient particulars such as name or address.
The main outcome measure was the major drug class prescribed in each antihypertensive drug visit as a proportion of all antihypertensive drug visits annually. Factors that may influence antihypertensive prescription choice included patients' age, gender, payment status (fee waivers vs payers), service types (GOPCs, FMSCs, staff clinics), district of residence, visit type (new or subsequent visits) and the calendar years of prescription. Fee waivers were mostly receiving social security allowances and payment status was thus regarded as a proxy measure for socioeconomic status.
The secondary outcome measure was the 180-day cumulative incidence of discontinuation and switching and their odds ratios for each drug class using CCBs as a reference. Discontinuation represents the absence of a refill prescription in subsequent visits without prescribing another antihypertensive drug class, whereas switching represents absence of a refill prescription in subsequent antihypertensive drug visits but replaced with another antihypertensive drug class. We included only drug-naive patients since previous antihypertensive drug users could have different drug tolerability responses. Antihypertensive drug visit was one unit for studying prescription patterns, and individual patient was one unit for comparing drug discontinuation and switching. Categorical variables were analysed by w 2 -tests. Multivariate regression analyses were performed to study the association between antihypertensive drug prescription and patient characteristics.
We compared the crude incidences of drug discontinuation and switching at 180 days by w 2 -tests among various drug classes, followed by multivariable logistic regression to study the odds ratios of discontinuation and switching, respectively, for each drug class using CCBs as a reference. Forward step-wise models were used as variable selection procedures.
We identified 67 113 eligible patients representing 1 069 836 antihypertensive drug visits. Average age was 65 years and most were women (59%). The detailed characteristics of this population have been reported previously.
2 CCBs (49.4%) and BBs (46.2%) were the most commonly prescribed drugs (Figure 1 
The majority of patients were on monotherapy (51.4%), followed by two class polytherapy (37.0%; Supplementary file 1). Compared with younger patients (o50-year old), elderly patients (X70 years) were less likely to receive BBs (adjusted odds ratio (aOR) 0.47; Supplementary file 2). Male patients were less likely to receive BBs (aOR 0.94) and thiazide diuretics (aOR 0.68). Regarding the fitness of the models, Nagelkerke r 2 ranged from 0.015 to 0.034 for these regression analyses, indicating that these associated factors combined explained o3.4% of the prescription outcome.
The crude cumulative incidence of drug discontinuation at 180 days was the highest for BBs (20.8%) and ACEIs (19.8%), whereas that of switching was the highest for thiazide diuretics (12.2%) and ACEIs (8.29%; Supplementary file 3). When controlled for other associated factors using CCBs as a reference, the eldest patients (aged X70 years) had lower drug switching rate (aOR 0.79, Po0.001; Supplementary file 4). Male patients were more likely to have drugs discontinued (aOR 1.07, P ¼ 0.012) but less likely to have drugs switched (aOR 0.77, Po0.001). When compared with CCBs, a-blockers (aOR 3.38) and BBs (aOR 2.38) were more likely to be discontinued. Thiazide diuretics were more likely (aOR 2.16) and BBs less likely (aOR 0.70) to be switched.
Similar patterns of prescribing have been reported in Hong Kong. 4, 5 However, the small size of these studies and that they were self-reported raise questions about accuracy and representativeness. Internationally, patterns and trends in antihypertensive prescribing vary widely between countries [6] [7] [8] [9] [10] (Supplementary file 5). Suggested factors to explain inter-country variation included reimbursement policies, traditions, domestic pharmaceutical production and clinical practice guidelines. 11 Elderly patients in this study were less likely to receive BBs, similarly reported in local and international studies. 7, 8 This is in line with guidelines highlighting greater efficacy of thiazide diuretics and CCBs in the elderly with respect to their lower renin status.
12 Male patients were less likely to receive thiazides and BBs, as physicians might perceive that thiazides could cause gouty attacks in men more frequently.
The 180-day discontinuation rates of antihypertensive drugs were different from Caucasian studies, most notably with the low discontinuation (12.0%) and switching rate (6.24%) of CCBs, which raise the possibility of ethnic differences.
The major strength of our study is the large sample size with high data completeness. 2 We excluded patients with concomitant cardiovascular conditions that allowed a more robust comparison of drug discontinuation profiles. However, our sample is from one territory, although similar patterns of What is known about topic K Internationally, patterns and trends in antihypertensive prescribing have been well described but few studies addressed prescription patterns among Chinese patients. K Discontinuation and switching profiles have also been extensively studied in Caucasian populations but few among ethnic Chinese.
What this study adds K From a total of 1 069 836 antihypertensive drug visits (67 028 patients), the most commonly prescribed drugs were calcium channel blockers (CCBs, 49%), b-blockers (BBs, 46%) and angiotensin-converting enzyme inhibitors (19%), with thiazide diuretic being low (13%) and its annual prescription trend on the decline. K Drug discontinuation was highest for BBs (21%) and lowest for CCBs (12%), whereas switching was less common than discontinuation and was most likely with thiazide diuretics. K CCBs may be a particularly favourable antihypertensive treatment in Chinese and the high discontinuation rates of BBs supported international guidelines advising against its use as a first-line therapy generalizable also to Chinese patients.
prescribing have been reported in other clusters of Hong Kong. 4 ,5 Also, we are unable to evaluate the reasons of drug discontinuation and switching, which should be more properly addressed by a prospective study.
To conclude, when compared with international trends, the prescription of CCBs and BBs are high and that of thiazide diuretics particularly low in this Chinese population. CCBs had more favourable discontinuation and switching profiles. The low use of thiazide diuretics warrants further clinical and cost effectiveness analysis.
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